
As GLP-1 receptor agonist medications like semaglutide have been shown to be effective at helping patients lose weight, scientists are now asking, whether they can treat other conditions where obesity is a risk factor. Most recently, initial studies have shown that they can reduce the risk of cardiovascular disease by reducing overall body weight.

Faculty, residents, trainees and students from Feinberg, the local community and beyond recently came together for Health Equity Week, a week-long series of educational programming designed to expose the roots of healthcare inequities as well as avenues to addressing them.

Women in the healthcare field and their allies convened in the Feinberg Pavilion at Northwestern Memorial Hospital to celebrate women’s empowerment and success during the sixth annual Women in Medicine Conference on March 8.